Skip to main content

International Pregnancy Safety Study

Project description

Fellowship to study prescription drugs during pregnancy

What are the risks and benefits of prescribed drug use during pregnancy? This question will be investigated by the newly established ‘International Pregnancy Safety Study’ (InPreSS) consortium, which brings together research groups with access to healthcare databases and demonstrated ability to study the safety of medications in pregnancy. This EU-funded project offers a global fellowship position at InPreSS. The fellow will be based at the Centre for Pharmacoepidemiology, Karolinska Institute (CPE/KI) in Sweden, with collaborators including researchers in all five Nordic countries and the Harvard School of Public Health (HSPH) in the US. The fellow will receive the highest quality support, facilitating long-term partnerships, training and contributing to the field with studies that impact clinical practice and guidelines for pregnant women.

Coordinator

KAROLINSKA INSTITUTET
Net EU contribution
€ 219 875,52
Address
Nobels Vag 5
17177 Stockholm
Sweden

See on map

Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00

Partners (1)

Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

PRESIDENT AND FELLOWS OF HARVARD COLLEGE
United States
Net EU contribution
€ 0,00
Address
Massachusetts Avenue 1350
02138 Cambridge

See on map

Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 123 949,44